Loading...
HSChapter 30
U.S. imports of pseudoephedrine-containing medicaments (not in dosage form) (HS 300342) totaled $17K in April 2026, traded with 1 country.
Last updated: April 2026 dataPseudoephedrine and its salts, classified as alkaloid-based medicaments under tariff line 3003420000, are subject to heightened regulatory scrutiny beyond standard FDA pharmaceutical oversight — the Combat Methamphetamine Epidemic Act and DEA regulations impose strict import controls, quota limits, and recordkeeping requirements on pseudoephedrine as a listed chemical precursor. India is the dominant US supplier for this heading, consistent with its role as a leading global API manufacturer. Importers must obtain DEA registration and comply with import quota allocations before any shipment can lawfully enter US commerce. Classification here applies only to non-dosage-form preparations; finished retail products follow a different tariff path.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Pseudoephedrine is a Schedule List I chemical under the Controlled Substances Act. Importers must hold a valid DEA importer registration, operate within an annually allocated import quota, and file advance notice of each importation. Shipments arriving without proper DEA authorization are subject to seizure regardless of FDA status.
Yes. Bulk pseudoephedrine API or salt shipments not yet put up in measured doses must be documented as chemical precursors rather than finished pharmaceuticals, which triggers both DEA listed-chemical controls and FDA drug-substance import procedures simultaneously. Importers should work with both agencies' import systems and ensure the commercial invoice clearly states the chemical name, CAS number, and quantity in kilograms.
Supplier Network
Get discovered by U.S. importers searching for HS 300342 — Pseudoephedrine-Containing Medicaments (Not in Dosage Form). Be the first supplier listed.
Monthly import values over time